Hollsteen
← Zscaler

Equity incl. NCI

Balance – as of period end · $M

QuartersFiscal years

$MEquity incl. NCI · Q1 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2016: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2016: −$125M · 10-K 0001628280-18-011833 filed Sep 13, 2018Equity incl. NCI · Q1 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q2 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q3 FY2017: missing – No verified SEC value extracted, although the company reports this metric in other periods.Equity incl. NCI · Q4 FY2017: −$151M · 10-K 0001628280-18-011833 filed Sep 13, 2018Equity incl. NCI · Q1 FY2018: −$161M · 10-Q 0001713683-18-000009 filed Dec 6, 2018Equity incl. NCI · Q2 FY2018: −$167M · 10-Q 0001713683-19-000006 filed Mar 6, 2019Equity incl. NCI · Q3 FY2018: $243M · 10-Q 0001713683-18-000007 filed Jun 7, 2018Equity incl. NCI · Q4 FY2018: $240M · 10-K 0001628280-18-011833 filed Sep 13, 2018Equity incl. NCI · Q1 FY2019: $252M · 10-Q 0001713683-18-000009 filed Dec 6, 2018Equity incl. NCI · Q2 FY2019: $277M · 10-Q 0001713683-19-000006 filed Mar 6, 2019Equity incl. NCI · Q3 FY2019: $287M · 10-Q 0001713683-19-000016 filed Jun 5, 2019Equity incl. NCI · Q4 FY2019: $309M · 10-K 0001713683-19-000030 filed Sep 18, 2019Equity incl. NCI · Q1 FY2020: $314M · 10-Q 0001713683-19-000053 filed Dec 6, 2019Equity incl. NCI · Q2 FY2020: $319M · 10-Q 0001713683-20-000037 filed Mar 4, 2020Equity incl. NCI · Q3 FY2020: $335M · 10-Q 0001713683-20-000095 filed Jun 3, 2020Equity incl. NCI · Q4 FY2020: $485M · 10-K 0001713683-20-000163 filed Sep 17, 2020Equity incl. NCI · Q1 FY2021: $492M · 10-Q 0001713683-20-000193 filed Dec 8, 2020Equity incl. NCI · Q2 FY2021: $503M · 10-Q 0001713683-21-000037 filed Mar 4, 2021Equity incl. NCI · Q3 FY2021: $508M · 10-Q 0001713683-21-000096 filed Jun 3, 2021Equity incl. NCI · Q4 FY2021: $529M · 10-K 0001713683-21-000175 filed Sep 16, 2021Equity incl. NCI · Q1 FY2022: $530M · 10-Q 0001713683-21-000238 filed Dec 8, 2021Equity incl. NCI · Q2 FY2022: $539M · 10-Q 0001713683-22-000029 filed Mar 9, 2022Equity incl. NCI · Q3 FY2022: $532M · 10-Q 0001713683-22-000056 filed Jun 9, 2022Equity incl. NCI · Q4 FY2022: $573M · 10-K 0001713683-22-000081 filed Sep 15, 2022Equity incl. NCI · Q1 FY2023: $431M · 10-Q 0001713683-22-000123 filed Dec 7, 2022Equity incl. NCI · Q2 FY2023: $529M · 10-Q 0001713683-23-000030 filed Mar 8, 2023Equity incl. NCI · Q3 FY2023: $601M · 10-Q 0001713683-23-000059 filed Jun 7, 2023Equity incl. NCI · Q4 FY2023: $725M · 10-K 0001713683-23-000113 filed Sep 14, 2023Equity incl. NCI · Q1 FY2024: $808M · 10-Q 0001713683-23-000171 filed Dec 6, 2023Equity incl. NCI · Q2 FY2024: $959M · 10-Q 0001713683-24-000041 filed Mar 6, 2024Equity incl. NCI · Q3 FY2024: $1.1B · 10-Q 0001713683-24-000075 filed Jun 7, 2024Equity incl. NCI · Q4 FY2024: $1.3B · 10-K 0001713683-24-000109 filed Sep 12, 2024Equity incl. NCI · Q1 FY2025: $1.4B · 10-Q 0001713683-24-000150 filed Dec 5, 2024Equity incl. NCI · Q2 FY2025: $1.6B · 10-Q 0001713683-25-000033 filed Mar 10, 2025Equity incl. NCI · Q3 FY2025: $1.8B · 10-Q 0001713683-25-000079 filed May 29, 2025Equity incl. NCI · Q4 FY2025: $1.8B · 10-K 0001713683-25-000158 filed Sep 11, 2025Equity incl. NCI · Q1 FY2026: $2.0B · 10-Q 0001713683-25-000205 filed Nov 25, 2025Equity incl. NCI · Q2 FY2026: $2.2B · 10-Q 0001713683-26-000048 filed Feb 26, 2026Equity incl. NCI · Q3 FY2026: $2.4B · 10-Q 0001713683-26-000096 filed May 26, 2026Equity incl. NCI · Q4 FY2026: $2.6B · 10-K 0001713683-26-000157 filed Sep 3, 20268082,598−125Q1 FY2016Q4 FY2026Q1 FY2024
$MEquity incl. NCI · Q1 FY2023: $431M · 10-Q 0001713683-22-000123 filed Dec 7, 2022Equity incl. NCI · Q2 FY2023: $529M · 10-Q 0001713683-23-000030 filed Mar 8, 2023Equity incl. NCI · Q3 FY2023: $601M · 10-Q 0001713683-23-000059 filed Jun 7, 2023Equity incl. NCI · Q4 FY2023: $725M · 10-K 0001713683-23-000113 filed Sep 14, 2023Equity incl. NCI · Q1 FY2024: $808M · 10-Q 0001713683-23-000171 filed Dec 6, 2023Equity incl. NCI · Q2 FY2024: $959M · 10-Q 0001713683-24-000041 filed Mar 6, 2024Equity incl. NCI · Q3 FY2024: $1.1B · 10-Q 0001713683-24-000075 filed Jun 7, 2024Equity incl. NCI · Q4 FY2024: $1.3B · 10-K 0001713683-24-000109 filed Sep 12, 20248081,274431Q1 FY2023Q4 FY2024Q1 FY2024
Q1 FY2024
808$M
All values (38)
PeriodValue ($M)Status
Q4 FY20262,598reported
Q3 FY20262,367reported
Q2 FY20262,196reported
Q1 FY20261,982reported
Q4 FY20251,799reported
Q3 FY20251,805reported
Q2 FY20251,607reported
Q1 FY20251,429reported
Q4 FY20241,274reported
Q3 FY20241,093reported
Q2 FY2024959reported
Q1 FY2024808reported
Q4 FY2023725reported
Q3 FY2023601reported
Q2 FY2023529reported
Q1 FY2023431reported
Q4 FY2022573reported
Q3 FY2022532reported
Q2 FY2022539reported
Q1 FY2022530reported
Q4 FY2021529reported
Q3 FY2021508reported
Q2 FY2021503reported
Q1 FY2021492reported
Q4 FY2020485reported
Q3 FY2020335reported
Q2 FY2020319reported
Q1 FY2020314reported
Q4 FY2019309reported
Q3 FY2019287reported
Q2 FY2019277reported
Q1 FY2019252reported
Q4 FY2018240reported
Q3 FY2018243reported
Q2 FY2018−167reported
Q1 FY2018−161reported
Q4 FY2017−151reported
Q1 FY2017 – Q3 FY2017–missing (3 periods): No verified SEC value extracted, although the company reports this metric in other periods.
Q4 FY2016Noneerror
Q1 FY2016 – Q3 FY2016–missing (3 periods): Grund wie bei Q1 FY2017 – Q3 FY2017.

Show reported periods only · CSV with all sources · Technical ID: equity_total

More metrics for Zscaler

Income statement

Per share

Balance sheet

Cash flow

Debt and interest

Revenue by segment/product/region

Sources & calculation
Value
$808M
Period
Q1 FY2024, ended Oct 31, 2023 · as of Oct 31, 2023 (balance as of date, not a sum)
Source
10-Q, filed Dec 6, 2023 · 0001713683-23-000171
Location
us-gaap:StockholdersEquity
Confidence
1. – directly from an XBRL fact in the filing (or calculated exactly from it)

Versions

v1$808MDec 6, 202310-Q 0001713683-23-000171reported · confidence 1. · current